Opioid Use after Transforaminal Lumbar Interbody Fusion: A Comparison between Open and Minimally Invasive Surgery

Abstract

Background Opioids are medications frequently used in patients with moderate and severe chronic pain. Their pharmacologic profile allows their use in acute severe postoperative pain. However, due to their highly addictive profile, opioid misuse is considered a public health issue. Vertebral spine fusion, decompression, and instrumentation are often associated with acute, severe postoperative pain. The present study aims to compare postoperative opioid consumption in a group of patients who underwent open transforaminal lumbar interbody fusion (OTLIF) against a similar group of patients who underwent minimally invasive transforaminal lumbar interbody fusion (MTLIF).

Methods We present a quantitative, observational, analytical, and historical cohort study. After convenience sampling, we identified 45 patients, 34 of whom underwent OTLIF and 11 underwent MTLIF. The analysis was made after measuring the following variables: demographics, type of surgery, length of stay, pain control, opioid type, and opioid dose. Statistical methods were implemented according to the origin and behavior of the variable.

Results We found a difference between significant and nonsignificant pain among the groups with less opioid consumption in the MTILF group. This difference was seen in the frequency and dosage during all observation periods. However, in the postoperative observation, the frequencies and dosages were equal between groups. According to linear regression, the type of surgery, radiculopathy, and radiculitis explain the significant postoperative pain in up to 50% of cases.

Conclusion Our study reveals a significant difference in opioid consumption between patients undergoing different surgical techniques. While these findings are valid for the studied population, the limitation in sample size highlights the need for further research. The implications of our findings on postoperative pain management and opioid use in spinal surgeries are significant and warrant continued investigation.

Keywords

spine - arthrodesis - neurosurgery - pain management - opioids

Publikationsverlauf

Eingereicht: 13. April 2024

Angenommen: 17. September 2024

Artikel online veröffentlicht:
19. November 2024

• References

• 1 Boulter JH, Curry BP, Welch MC. et al. 199 protocolization of post-transforaminal lumbar interbody fusion pain control with elimination of benzodiazepines and long-acting opioids. Neurosurgery 2018; 65 (CN_suppl_1): 115-115
• 2 Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA Netw Open 2018; 1 (02) e180217
• 3 Wilson N, Kariisa M, Seth P, Smith IV H, Davis NL. Drug and opioid-involved overdose deaths: United States, 2017-2018. MMWR Morb Mortal Wkly Rep 2020; 69 (11) 290-297
• 4 Florence CS, Zhou C, Luo F, Xu L. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care 2016; 54 (10) 901-906
• 5 Oleisky ER, Pennings JS, Hills J. et al. Comparing different chronic preoperative opioid use definitions on outcomes after spine surgery. Spine J 2019; 19 (06) 984-994
• 6 Volinn E, Fargo JD, Fine PG. Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. Pain 2009; 142 (03) 194-201
• 7 Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use: United States, 2006-2015. MMWR Morb Mortal Wkly Rep 2017; 66 (10) 265-269
• 8 Mendoza-Elias N, Dunbar M, Ghogawala Z, Whitmore RG. Opioid use, risk factors, and outcome in lumbar fusion surgery. World Neurosurg 2020; 135: e580-e587
• 9 Deyo RA, Hallvik SE, Hildebran C. et al. Use of prescription opioids before and after an operation for chronic pain (lumbar fusion surgery). Pain 2018; 159 (06) 1147-1154
• 10 Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers: United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011; 60 (43) 1487-1492
• 11 Ge DH, Hockley A, Vasquez-Montes D. et al. Total inpatient morphine milligram equivalents can predict long-term opioid use after transforaminal lumbar interbody fusion. Spine 2019; 44 (20) 1465-1470
• 12 Armaghani SJ, Lee DS, Bible JE. et al. Increased preoperative narcotic use and its association with postoperative complications and length of hospital stay in patients undergoing spine surgery. Clin Spine Surg 2016; 29 (02) E93-E98
• 13 Kaito T, Matsuyama Y, Yamashita T. et al; Project Committee of the Japanese Society for Spine Surgery and Related Research (JSSR). Cost-effectiveness analysis of the pharmacological management of chronic low back pain with four leading drugs. J Orthop Sci 2019; 24 (05) 805-811
• 14 Cheng JS, Park P, Le H, Reisner L, Chou D, Mummaneni PV. Short-term and long-term outcomes of minimally invasive and open transforaminal lumbar interbody fusions: is there a difference?. Neurosurg Focus 2013; 35 (02) E6
• 15 Lee MJ, Mok J, Patel P. Transforaminal lumbar interbody fusion: traditional open versus minimally invasive techniques. J Am Acad Orthop Surg 2018; 26 (04) 124-131
• 16 Ly DP. Evaluation and treatment patterns of new low back pain episodes for elderly adults in the United States, 2011-2014. Med Care 2020; 58 (02) 108-113
• 17 Khor S, Lavallee D, Cizik AM. et al. Development and validation of a prediction model for pain and functional outcomes after lumbar spine surgery. JAMA Surg 2018; 153 (07) 634-642